FLGT

FULGENT GENETICS INC

FLGT·359664109·US·Common Stock·Healthcare - Diagnostics & Research-Activist

FLGT (FULGENT GENETICS INC) is held by 92 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($44.1M), RTW INVESTMENTS, LP ($20.5M), VANGUARD CAPITAL MANAGEMENT LLC ($14M). Net institutional sentiment: Mixed. In Q1 2026, 1 member of Congress and 43 funds bought FLGT.

92
Holders
Avg rating(21 Elite)
$223.4M
Total Value
43% (107)
Fund Consensus
43 buying - 56 selling
FLGTSmart Money Verdict
View all
Held by 92 funds
21 elite
Who's Trading
ActivistMHMing Hsieh32.3%May 27, 2026
InsiderGHGao HanlinTax 2K shApr 26, 2026
InsiderXJXie JianTax 4K shApr 26, 2026
InsiderKPKim PaulTax 3K shApr 26, 2026
ActivistMHMing Hsieh30.7%Mar 31, 2026
InsiderGHGao HanlinSell $28KNov 28, 2025
CongressDonald J. TrumpDonald J. TrumpSale $1,001 - $15,000Mar 24, 2025
CongressDonald J. TrumpDonald J. TrumpBuy $1,001 - $15,000Mar 11, 2025
CongressDonald J. TrumpDonald J. TrumpBuy $1,001 - $15,000Jan 30, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
2.8M(-6.3%)$44.1M0.0%+5.49%
0
Increased
1.3M(+82.8%)$20.5M0.2%-0.90%
52
New
880,150$14M0.0%+49.02%
39
Decreased
671,664(-24.4%)$10.7M0.0%-29.58%
0
Increased
584,207(+14.9%)$9.3M0.0%-52.45%
32
Increased
563,375(+12.8%)$9M0.0%-15.79%
31
Increased
529,399(+7.2%)$8.4M0.0%-24.68%
30
Decreased
486,770(-30.6%)$7.7M0.0%-0.19%
0
Increased
460,363(+84.0%)$7.2M0.0%+13.09%
42
Decreased
401,819(-57.2%)$6.4M0.0%-3.91%
0
New
356,359$5.7M0.0%+49.02%
37
Decreased
354,184(-12.1%)$5.6M0.0%-37.66%
0
Decreased
325,446(-25.9%)$5.2M0.0%-6.39%
0
Increased
322,189(+8.3%)$5.1M0.0%-10.32%
29
Decreased
311,423(-10.7%)$5M0.0%-10.18%
0
Decreased
302,564(-19.3%)$4.8M0.0%+5.59%
0
Increased
240,759(+188.1%)$3.8M0.0%+16.34%
43
New
215,854$3.4M0.0%+49.02%
37
Decreased
192,403(-39.0%)$3.1M0.0%-2.06%
0
Increased
182,113(+1.8%)$2.9M0.0%-55.58%
27

Showing 1-20 of 107

1 / 6

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used